Metabolism and Target Organ Damage

Search For

13 result(s) for ‘diabetes’

Open Access Review

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Amedeo Lonardo, Gjin Ndrepepa

This article belongs to the Special Issue Laboratory Medicine in Metabolic Disorders and Target Organ Damage

Metab Target Organ Damage 2022;2:17.

DOI: 10.20517/mtod.2022.20

Published on: 30 Sep 2022 Viewed: 1859 Downloaded: 395

View Full-Text Download PDF
Open Access Review

Arresting type 1 diabetes: are we there yet? Obstacles and opportunities

Chantal Mathieu, Pieter-Jan Martens

This article belongs to the Special Issue The Complications of Diabetes

Metab Target Organ Damage 2022;2:15.

DOI: 10.20517/mtod.2022.16

Published on: 28 Sep 2022 Viewed: 1214 Downloaded: 522

View Full-Text Download PDF
Open Access Review

MAFLD under the lens: the role of gut microbiota

Patrícia Sousa, Mariana Verdelho Machado

Metab Target Organ Damage 2022;2:14.

DOI: 10.20517/mtod.2022.15

Published on: 28 Sep 2022 Viewed: 944 Downloaded: 215

View Full-Text Download PDF
Open Access Review

Glycaemic control strategies in people with type 2 diabetes mellitus undergoing elective surgery

Naomi M. Fearon, Dimitri J. Pournaras

This article belongs to the Special Issue The Complications of Diabetes

Metab Target Organ Damage 2022;2:13.

DOI: 10.20517/mtod.2022.12

Published on: 6 Sep 2022 Viewed: 310 Downloaded: 178

View Full-Text Download PDF
Open Access Review

Metabolism and cancer-select topics

Fulvio Lonardo, Casem Ballouk

Metab Target Organ Damage 2022;2:8.

DOI: 10.20517/mtod.2022.05

Published on: 6 May 2022 Viewed: 897 Downloaded: 260

View Full-Text Download PDF
Open Access Review

Liver transplantation and nonalcoholic steatohepatitis: the state of the art

Stefano Gitto, ... Pietro Andreone

Metab Target Organ Damage 2022;2:7.

DOI: 10.20517/mtod.2022.04

Published on: 18 Apr 2022 Viewed: 636 Downloaded: 173

View Full-Text Download PDF
Open Access Review

Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus

Pablo Solís-Muñoz, ... Águeda González-Rodríguez

Metab Target Organ Damage 2022;2:5.

DOI: 10.20517/mtod.2021.18

Published on: 15 Mar 2022 Viewed: 738 Downloaded: 190

View Full-Text Download PDF
Open Access Systematic Review

Male hypogonadism and pre-diabetes interplay: association or causal interaction? A systematic review

Carla Greco, ... Daniele Santi

Metab Target Organ Damage 2021;1:11.

DOI: 10.20517/mtod.2021.14

Published on: 2 Dec 2021 Viewed: 1112 Downloaded: 353

View Full-Text Download PDF
Open Access Review

The Fatty liver Index (FLI) 15 years later: a reappraisal

Amedeo Lonardo, ... Claudio Tiribelli

Metab Target Organ Damage 2021;1:10.

DOI: 10.20517/mtod.2021.08

Published on: 19 Nov 2021 Viewed: 3227 Downloaded: 1133

View Full-Text Download PDF
Open Access Original Article

Expression of TGR5 in adipose tissue in relation to metabolic impairment and adipose tissue dysfunction in human obesity

Ilaria Barchetta, ... Maria Gisella Cavallo

Metab Target Organ Damage 2021;1:8.

DOI: 10.20517/mtod.2021.04

Published on: 17 Sep 2021 Viewed: 1685 Downloaded: 797

View Full-Text Download PDF
Open Access Commentary

Nonalcoholic fatty liver disease in type 2 diabetes: A bad omen. But can we do something to change it?

Fernando Bril

Metab Target Organ Damage 2021;1:5.

DOI: 10.20517/mtod.2021.06

Published on: 18 Aug 2021 Viewed: 836 Downloaded: 203

View Full-Text Download PDF
Open Access Review

Risk of cardio-nephro-metabolic disease from NAFLD to MAFLD: fact or fiction?

Ramzi Hassouneh, ... Chandra Bhati

Metab Target Organ Damage 2021;1:4.

DOI: 10.20517/mtod.2021.07

Published on: 17 Aug 2021 Viewed: 1681 Downloaded: 753

View Full-Text Download PDF
Open Access Review

Precision medicine approaches in metabolic disorders and target organ damage: where are we now, and where are we going?

Amedeo Lonardo, ... Giovanni Targher

Metab Target Organ Damage 2021;1:3.

DOI: 10.20517/mtod.2021.03

Published on: 26 Jul 2021 Viewed: 2949 Downloaded: 1562

View Full-Text Download PDF

Hot Keywords

Search For

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Arresting type 1 diabetes: are we there yet? Obstacles and opportunities

MAFLD under the lens: the role of gut microbiota

Glycaemic control strategies in people with type 2 diabetes mellitus undergoing elective surgery

Metabolism and cancer-select topics

Liver transplantation and nonalcoholic steatohepatitis: the state of the art

Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus

Male hypogonadism and pre-diabetes interplay: association or causal interaction? A systematic review

The Fatty liver Index (FLI) 15 years later: a reappraisal

Expression of TGR5 in adipose tissue in relation to metabolic impairment and adipose tissue dysfunction in human obesity

Nonalcoholic fatty liver disease in type 2 diabetes: A bad omen. But can we do something to change it?

Risk of cardio-nephro-metabolic disease from NAFLD to MAFLD: fact or fiction?

Precision medicine approaches in metabolic disorders and target organ damage: where are we now, and where are we going?

Metabolism and Target Organ Damage

Navigation

follow us

OAE Publishing Inc.

OAE JOURNALS

FOLLOW OAE